Medapharma.gr valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Mylan - Better Health for a Better World |
| Description | Γιατί Mylan; Επειδή με το πάθος, την καινοτομία και την αφοσίωσή μας θέτουμε νέα πρότυπα στη φροντίδα υγείας. Seeing is believing. |
| Keywords | Mylan, γενόσημα, φαρμακευτική, ποιότητα, φάρμακο, pharma, καινοτομία, εξυπηρέτηση, πρόσβαση, εμπιστοσύνη |
Server Information
| WebSite | |
| Host IP | 52.202.246.143 |
| Location | Ashburn, Virginia, United States |
Related Websites
| Site | Rank |
| orlpedia.gr | #2,284,588 |
| ericardoanaya.com | #2,207,347 |
More to Explore
Medapharma.gr Valuation
|
US$1,997
Last updated: Jan 18, 2020
Medapharma.gr has global traffic rank of 8,438,454. Medapharma.gr has an estimated worth of US$ 1,997, based on its estimated Ads revenue. Medapharma.gr receives approximately 364 unique visitors each day. Its web server is located in Ashburn, Virginia, United States, with IP address 52.202.246.143. According to SiteAdvisor, medapharma.gr is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,997 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$32 |
| Yearly Ads Revenue | US$399 |
| Daily Unique Visitors | 364 |
| Note: All traffic and earnings values are estimates. | |
Traffic Ranks
| Global Rank | 8,438,454 |
| Delta (90 Days) | 0 |
| Most Popular In Country | N/A |
| Country Rank | N/A |
DNS Records
| Host | Type | TTL | Data |
| medapharma.gr | A | 59 | IP: 52.45.26.137 |
| medapharma.gr | A | 59 | IP: 52.202.246.143 |
| medapharma.gr | A | 59 | IP: 54.174.78.119 |
| medapharma.gr | MX | 299 | Priority: 20 Target: meda-se.mx2.staysecuregroup.net. |
| medapharma.gr | MX | 299 | Priority: 10 Target: meda-se.mx1.staysecuregroup.com. |
| medapharma.gr | NS | 21599 | Target: ns-1966.awsdns-53.co.uk. |
| medapharma.gr | NS | 21599 | Target: ns-397.awsdns-49.com. |
| medapharma.gr | NS | 21599 | Target: ns-802.awsdns-36.net. |
| medapharma.gr | NS | 21599 | Target: ns-1320.awsdns-37.org. |
| medapharma.gr | TXT | 299 | TXT: 5p8SW49GHJ8R/a3lDnAn1GG6Vz4/wyZya16C3Tft0imzfd1LUrMbtkLvMR7LKh3o2woMStTfIlj0+TkOLBrfpQ== |
| medapharma.gr | TXT | 299 | TXT: v=spf1 mx ip4:178.79.170.179 ip6:2a01:7e00::f03c:91ff:fe6e:1995 include:_spf.staysecuregroup.com ~all |
| medapharma.gr | SOA | 899 | MNAME: ns-397.awsdns-49.com. RNAME: awsdns-hostmaster.amazon.com. Serial: 1 Refresh: 7200 Retry: 900 Expire: 1209600 Minimum TTL: 86400 |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sat, 18 Jan 2020 07:04:35 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 143 Connection: keep-alive Set-Cookie: AWSALB=HPD+1GHgvKTpBeL4wLiKlhYgwyDKb0HUWkO/Da0lLrNGWE+/FvqoBaRN1Y4BfW1L9kaAftiHpaoPealBLvIu1grlW3GnmwSay0ormnYj0lSgKy1hoA0HFghMVtjl; Expires=Sat, 25 Jan 2020 07:04:35 GMT; Path=/ Location: https://www.mylan.gr Server: X-Powered-By: X-Responding-Host: RESPONSE_X-POWERED-BY: .* RESPONSE_X-ASPNET-VERSION: .* RESPONSE_SERVER: .* X-Server: i-0c7b8a23653e7090e X-ASPNET-VERSION: HTTP/2 200 date: Sat, 18 Jan 2020 07:04:36 GMT content-type: text/html; charset=utf-8 content-length: 86664 set-cookie: AWSALB=YzV5C+hwCxjnQ1IJht8Wi3u04+pr8N9iXLWef0VZB6b48TuYphVQl2Y2T+t0qkm0aK/Cp6kaaUeaYyB3BjwiV6RUzIdNWJ9VA38B6XsLMKx3NqWGkRU6FHPqGJN+; Expires=Sat, 25 Jan 2020 07:04:36 GMT; Path=/ cache-control: private server: set-cookie: ASP.NET_SessionId=nb1eui2pvtnoumdkpsb5p51m; path=/; HttpOnly x-aspnetmvc-version: 5.1 x-aspnet-version: set-cookie: SC_ANALYTICS_GLOBAL_COOKIE_MylanGR=8cec32a1bd3a4b379488ec71586a4fc1; expires=Fri, 18-Jan-2030 07:04:20 GMT; path=/; HttpOnly set-cookie: SC_ANALYTICS_SESSION_COOKIE_MylanGR=10B6CA76E1C740789D08AB8BE80934F5|1|nb1eui2pvtnoumdkpsb5p51m; path=/; HttpOnly x-powered-by: x-responding-host: response_x-powered-by: .* response_x-aspnet-version: .* response_server: .* x-server: i-060ee141603c37a64 |
Medapharma.gr Whois Information
This TLD has no whois server, but you can access the whois database at https://grweb.ics.forth.gr/public/whois |